Mr. Bush criticized Canonsburg, Pa.-based Mylan, saying that raising the price of EpiPens “too much too quickly” is “dumb business.”
He asserted the EpiPen pricing controversy only a national issue because it’s a widely used product that underwent major price increases at a time when the public feels like “there’s no more room for the healthcare dollar in the budget,” Mr. Bush said.
Fox Business’ Dagen McDowell agreed with Mr. Bush saying, “They use it as a political issue because it involves children, which definitely plays to people’s hearts.”
More articles on supply chain:
5 reasons insurance claims should include UDIs
Senate committee to examine Mylan’s Medicaid rebates
Sarepta plans to sell $225M of stock to support clinical trials, drug commercialization
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
